Infertility as the onset of Cushing’s disease: is pasireotide a treatment option?

1. Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008). Cushing’s Syndrome. Endocrinol Metab Clin North Am, 37(1), 135-149, ix. doi: 10.1016/j. ecl.2007.10.010Search in Google Scholar

2. Shah, D. & Patel, S. (2009). Hirsutism. Gynecol Endocrinol, 25 (3),140-148.10.1080/09513590802531567Search in Google Scholar

3. Sharma, J.B., Roy, K.K., Mohanraj, P., Kumar ,S., Karmakar, D. & Barua, J. (2009). Pregnancy outcome in pituitary tumors. Arch Gynecol Obstet. 280 (3),401-404.10.1007/s00404-008-0917-8Search in Google Scholar

4. Poullot, A-G. & Chevalier, N. (2013). New options in the treatment of Cushing’s disease: a focus on pasireotide. Research and Reports in Endocrine Disorders. 3,31-38.Search in Google Scholar

5. Aron, D.C., Schnall, A.M. & Sheeler, L.R. Cushing’s syndrome and pregnancy. Am J Obstetrics and gynecology, 162 (1),244-252.10.1016/0002-9378(90)90859-6Search in Google Scholar

6. Ursula, B. (2012). Hyperprolactinemia and infertility: new insight. J Clin Invest. 122 (10), 3791-3795.Search in Google Scholar

7. Gadelha, M.R., Viera Neto, L. (2014). Efficacy of medical treatment in Cushing’s disease: a systeamtic review, Clin Endocrinol (Oxf). 80 (1):1-12Search in Google Scholar

8. Bertagna, X & Guignat, L. (2013). Approach to the Cushing's disease patient with persistent/ recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab. 98(4):1307-18. doi: 10.1210/jc.2012-3200.10.1210/jc.2012-320023564942Search in Google Scholar